180 related articles for article (PubMed ID: 19390858)
1. ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery.
Baiocchi G; Lopes A; Coudry RA; Rossi BM; Soares FA; Aguiar S; Guimarães GC; Ferreira FO; Nakagawa WT
Int J Colorectal Dis; 2009 Sep; 24(9):1059-68. PubMed ID: 19390858
[TBL] [Abstract][Full Text] [Related]
2. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery.
Lee JC; Wang ST; Chow NH; Yang HB
Eur J Cancer; 2002 May; 38(8):1065-71. PubMed ID: 12008194
[TBL] [Abstract][Full Text] [Related]
4. ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance.
Galanakis I; Spyropoulos E; Gkialas I; Nomikos A; Souka E; Mitropoulos D
J BUON; 2013; 18(3):653-9. PubMed ID: 24065479
[TBL] [Abstract][Full Text] [Related]
5. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
[TBL] [Abstract][Full Text] [Related]
6. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.
Bei R; Pompa G; Vitolo D; Moriconi E; Ciocci L; Quaranta M; Frati L; Kraus MH; Muraro R
J Pathol; 2001 Oct; 195(3):343-8. PubMed ID: 11673832
[TBL] [Abstract][Full Text] [Related]
7. Expression of NRG1 and its receptors in human bladder cancer.
Forster JA; Paul AB; Harnden P; Knowles MA
Br J Cancer; 2011 Mar; 104(7):1135-43. PubMed ID: 21364580
[TBL] [Abstract][Full Text] [Related]
8. [Relationship of expression of C-erbB2, C-erbB3, and C-erbB4 with ovarian carcinoma].
Li L; Zhong YP; Zhang W; Zhang JQ; Yao ZQ
Ai Zheng; 2004 May; 23(5):568-72. PubMed ID: 15142456
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.
Maurer CA; Friess H; Kretschmann B; Zimmermann A; Stauffer A; Baer HU; Korc M; Büchler MW
Hum Pathol; 1998 Aug; 29(8):771-7. PubMed ID: 9712416
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
Chow NH; Chan SH; Tzai TS; Ho CL; Liu HS
Clin Cancer Res; 2001 Jul; 7(7):1957-62. PubMed ID: 11448910
[TBL] [Abstract][Full Text] [Related]
11. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.
Huang Z; Wang SL; Chen H; Shen RK; Li XD; Huang QS; Wu CY; Weng DF; Lin JH
Scand J Clin Lab Invest; 2019 Dec; 79(8):601-612. PubMed ID: 31663373
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.
Gulati S; Ytterhus B; Granli US; Gulati M; Lydersen S; Torp SH
Diagn Pathol; 2010 Mar; 5():18. PubMed ID: 20331873
[TBL] [Abstract][Full Text] [Related]
15. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Mill CP; Gettinger KL; Riese DJ
Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of ERBB4 expression in patients with triple negative breast cancer.
Kim JY; Jung HH; Do IG; Bae S; Lee SK; Kim SW; Lee JE; Nam SJ; Ahn JS; Park YH; Im YH
BMC Cancer; 2016 Feb; 16():138. PubMed ID: 26907936
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects.
Polosa R; Puddicombe SM; Krishna MT; Tuck AB; Howarth PH; Holgate ST; Davies DE
J Allergy Clin Immunol; 2002 Jan; 109(1):75-81. PubMed ID: 11799369
[TBL] [Abstract][Full Text] [Related]
18. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.
Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016
[TBL] [Abstract][Full Text] [Related]
19. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.
Lee D; Yu M; Lee E; Kim H; Yang Y; Kim K; Pannicia C; Kurie JM; Threadgill DW
J Clin Invest; 2009 Sep; 119(9):2702-13. PubMed ID: 19690388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]